School HPV vaccine push aims to protect teens from cancer
NCT ID NCT07414719
First seen Feb 18, 2026 · Last updated Apr 29, 2026 · Updated 10 times
Summary
This study tests a new program in middle and high schools to encourage HPV vaccination among 11-17 year olds. HPV is a common virus that can cause cancer, but vaccination rates in France are low. The program will be compared to standard care to see if it increases the number of teens who get at least one vaccine dose within 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIDDLE SCHOOL AND HIGH SCHOOL STUDENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lycée BELTRAME
RECRUITINGSaint-Priest, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.